Skip to main content
Log in

Toxicity of 1-(β-d-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye

  • Laboratory Investigations
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

The retinal toxicity of intravitreally injected 1-(β-d-arabinofuranosyl)cytosine (cytarabine) was examined in 7 chinchilla rabbits to determine if cytarabine can be used as local therapy for vitreoretinal non-Hodgkin's lymphoma. Fractionated dose of 600 μg, 1500 μg, and 2700 μg cytarabine in stabilized saline were given intravitreally in one eye (2 × 300 μg, 5 × 300 μg, and 3 × 900 μg, respectively, with an interval time of 24 h) and stabilized saline in the other eye as control. Toxic effects were evaluated with biomicroscopy, direct ophthalmoscopy, fluorophotometry, electroretinography, light, and electron microscopy. Toxic effects were found with the 1500 μg and 2700 μg doses only. They consisted of a temporary impairment of the blood retina barrier function for fluorescein as measured by fluorophotometry and an irreversible change of the b-wave in the electroretinograms. No histopathologic changes were seen under the light microscope. Electron microscopic examination showed aberrations in the synaptic pedicles of the photoreceptor cells at a dose of 1500 μg cytarabine. The results suggest that the cytarabine dose that is expected to be therapeutic for vitreoretinal non-Hodgkin's lymphoma (about 90 μg given in three doses of 30 μg) is non-toxic for ocular structures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barrada A, Peyman GA, Case J, Fishman GA, Thomas A, Fiscella R (1984) Evaluation of intravitreal 5-FU, vincristine, Vp 16, doxorubicin and thiotepa in primate eyes. Ophthalmic Surg 15:767–769

    Google Scholar 

  2. Barrada A, Peyman GA, Greenberg D, Stelmack T, Fiscella R (1983) Toxicity of antineoplastic drugs in vitrectomy infusion fluids. Ophthalmic Surg 14:845–847

    Google Scholar 

  3. Baum J, Peyman GA, Barza M (1982) Intravitreal administration of antibiotic in the treatment of bacterial endophthalmitis. III. Consensus. Surv Ophthalmol 26:204–206

    Google Scholar 

  4. Baumann MA, Ritch PS, Hande KR, Williams GA, Topping TM, Anderson T (1986) Treatment of intraocular lymphoma with high dose Ara-C. Cancer 57:1273–1275

    CAS  PubMed  Google Scholar 

  5. Brown KT (1968) The electroretinogram: its components and their origins. Vision Res 8:633–677

    Google Scholar 

  6. Chabner BA (1990) Cytidine analogues. In: Chabner BA (ed) Cancer chemotherapy. Lippincott, Philadelphia, pp 154–167

    Google Scholar 

  7. Char DH, Ljung BM, Miller T, Phillips T (1988) Primary intraocular lymphoma (ocular reticulum cell sarcoma): diagnosis and management. Ophthalmology 95:625–630

    CAS  PubMed  Google Scholar 

  8. Char DH, Margolis L, Newman AB (1981) Ocular reticulum cell sarcoma. Am J Ophthalmol 91:480–483

    Google Scholar 

  9. Colly LP, van Bekkum DW (1982) A recommendation for high dose Ara-C treatment based on studies on a slow growing leukemia model (BNML). Med Pediatr Oncol 209 [Suppl 1]:209–220

    Google Scholar 

  10. Colly LP, Peters WG, Willemze R (1986) Effect of the interval between high dose 1-(β-δ-arabinofuranosyl)cytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model. Cancer Res 46:3825–3827

    Google Scholar 

  11. Dowling JE (1987) The electroretinogram and glial responses. In: Dowling JE (ed) The retina: an approachable part of the brain. Belknap Press, Harvard University, London, pp 165–186

    Google Scholar 

  12. Drenthe-Schonk AM (1982) Clinical and pharmacological studies on cytosine arabinoside in acute leukemia. Thesis, University of Nijmegen, The Netherlands

    Google Scholar 

  13. Fiscella R, Elvart J, Peyman GA, Yue B (1985) In vitro evaluation of cellular inhibitory potential of various antineoplastic drugs and dexamethasone. Ophthalmic Surg 16:247–249

    Google Scholar 

  14. Fraunfelder FT (1990) Lymphoid tumors. In: Fraunfelder FT, Roy HIT (eds) Current ocular therapy, 3rd edn. Saunders, Philadelphia, pp 297–299

    Google Scholar 

  15. Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR (1987) Clinical features, laboratory investigations and survival in ocular reticulum cell sarcoma. Ophthalmology 94:1631–1639

    Google Scholar 

  16. Garntner S (1990) Metastatic carcinoma to the eye and adnexa. In: Duane TD (ed) Clinical ophthalmology, Chap. 34. Lippincott, Philadelphia, pp 1–11

    Google Scholar 

  17. Hajek AS, Parrish RK II, Mallick KS, Gressel M (1986) In vitro inhibition of ocular cell proliferation with Ara-C; blockage of the antiproliferative effect with 2′-deoxycytidine. Invest Ophthalmol Vis Sci 27:1010–1012

    Google Scholar 

  18. Hande KR, Stein RS, McDonough DA, Greco FA, Wolff SN (1982) Effects of high-dose cytarabine. Clin Pharmacol Ther 31:674–699

    Google Scholar 

  19. Harris AL, Grahame-Smith DG (1982) The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukemia. Cancer Chem Pharmacol 9:30–35

    Google Scholar 

  20. Ho DHW, Frei E (1971) Clinical pharmacology of 1-(β-d-ara-binofuranosyl)cytosine. Clin Pharmacol Ther 12:944–954

    Google Scholar 

  21. Kaplan HJ, Meredith TA, Aaberg TM, Keller RH (1980) Reclassification of intraocular reticulum cell sarcoma (histiocytic lymphoma): immunologic characterization of vitreous cells. Arch Ophthalmol 98:707–710

    Google Scholar 

  22. Karp JE, Donehower RC, Burke PJ (1987) An in vitro model to predict clinical response in adult acute myelogenous leukemia. Semin Oncol 14 [Suppl 1]:172–181

    Google Scholar 

  23. Kincaid MC (1988) Ocular and orbital tumors. Ophthalmology 95:1588–1595

    Google Scholar 

  24. Kline RP, Ripps H, Dowling JE (1978) Generation of b-wave currents in the skate retina. Proc Natl Acad Sci USA 475:5727–5731

    Google Scholar 

  25. Kuming BS, Fritz VU, Bezwoda WR (1988) Ocular reticulum cell sarcoma. S Afr Med J 73:49–53

    Google Scholar 

  26. Liu K-R, Peyman GA, She S-C, Niesman MR, Khoobehi B (1989) Reduced toxicity of intravitreally injected liposome-encapsulated cytarabine. Ophthalmic Surg 20:358–361

    Google Scholar 

  27. Newman EA (1987) Regulation of potassium levels by Müller cells in the vertebrate retina. Can J Physiol Pharmacol 65:1028–1032

    Google Scholar 

  28. Peyman GA, Greenberg D, Fishman GA, Fiscella R, Thomas A (1984) Evaluation of toxicity of intravitreal antineoplastic drugs. Ophthalmic Surg 15:411–413

    Google Scholar 

  29. Putting BJ, Zweypfenning RCVJ, Vrensen GFJM, Oosterhuis JA, Best JA van (1992) Dysfunction and repair of the blood retina barrier following white light exposure: a fluorophotometric and histologic study. Invest Ophthalmol Vis Sci 54:133–141

    Google Scholar 

  30. Qualman SJ, Mendelsohn G, Mann RB, Green WR (1983) Intraocular lymphomas: natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer 52:878–886

    Google Scholar 

  31. Raijmakers R, De Witte T, Linssen P, Wessels J, Haanen C (1986) The relation of exposure time and drug concentration in their effect on cloning efficiency after incubation of human bone marrow with cytosine arabinoside. Br J Haematol 62:447–453

    Google Scholar 

  32. Reichenbach A, Eberhardt W (1986) Intracellular recordings from isolated rabbit retinal Müller (glial) cells. Pflügers Arch 407:348–353

    Google Scholar 

  33. Ritch PS, Hansen RM, Heuer DK (1983) Ocular toxicity from high-dose cytosine arabinoside. Cancer 51:430–432

    Google Scholar 

  34. Rouwen AJP, Wijermans PW, Boen-Tan TN, Stilma JS (1989) Intraocular non-Hodgkin's lymphoma treated with systemic and intrathecal chemotherapy and radiotherapy. A case report and review of the literature Greafe's Arch Clin Exp Ophthalmol 227:355–359

    Google Scholar 

  35. Siegel MJ, Dalton J, Friedman AH, Strauchen J, Watson C (1989) Ten-year experience with primary ocular reticulum cell sarcoma (large cell non-Hodgkin's lymphoma). Br J Ophthalmol 73:342–346

    Google Scholar 

  36. Sizoo W, Van Andel JG, Baarsma GS, Wielenga JJ (1988) Non Hodgkin's lymphoma of the corpus vitreum. Neth J Med 33:26–29

    Google Scholar 

  37. Sloas HA, Starling J, Harper DG, Cupples HP (1981) Update of ocular reticulum cell sarcoma. Arch Ophthalmol 99:1048–1052

    Google Scholar 

  38. Swart W, Keizer RJW de (1986) Toxic keratitis following systematically administered Ara-C (cytarabine) Ophthalmologica 192:116–117

    Google Scholar 

  39. Vrensen GFJM (1989) Learning, memory and long-term synaptic plasticity in the mammalian brain. Prog Zool 37:132–147

    Google Scholar 

  40. Woodcock DM (1987) Cytosine arabinoside toxicity: molecular events, biological consequences, and their implications. Semin Oncol 14 [Suppl 1]:251–256

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: J.A. van Best

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diets-Ouwehand, J.J.A.T., de Keizer, R.J.W., F.J.M. Vrensen, G. et al. Toxicity of 1-(β-d-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye. Graefe's Arch Clin Exp Ophthalmol 230, 488–495 (1992). https://doi.org/10.1007/BF00175939

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00175939

Keywords

Navigation